Tennant (TNC)
(Delayed Data from NYSE)
$83.19 USD
-4.37 (-4.99%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $83.16 -0.03 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$83.19 USD
-4.37 (-4.99%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $83.16 -0.03 (-0.04%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Zacks News
Stanley Black Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Stanley Black (SWK) withdraws projections for 2020, expecting demand disruptions caused by the coronavirus outbreak. It also expects lowering costs and capital expenditure for the time being.
Astec (ASTE) Surges: Stock Moves 6.9% Higher
by Zacks Equity Research
Astec (ASTE) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Here's Why You Should Avoid Betting on IDEX (IEX) Stock Now
by Zacks Equity Research
IDEX (IEX) has been suffering from difficult end-market conditions and several other issues.
Here's Why Investors Should Ignore Applied Industrial (AIT)
by Zacks Equity Research
Applied Industrial (AIT) is exposed to weakness in industrial demand, which might hurt its performance in fiscal 2020. Also, high debts and forex woes might be concerning.
Xylem (XYL) Withdraws Guidance Based on Coronavirus Concerns
by Zacks Equity Research
Xylem (XYL) withdraws guidance for the first quarter and 2020, owing to the coronavirus outbreak.
Berry Global (BERY) Invests in Specialty Meltblown Asset
by Zacks Equity Research
Berry Global (BERY) increases its investment in an additional specialty meltblown asset for the production of high-efficiency filtration media for the EMEIA markets.
Flowserve (FLS) Catches Eye: Stock Jumps 6.2%
by Zacks Equity Research
Flowserve (FLS) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
Honeywell Increases N95 Face Mask Production at Phoenix Site
by Zacks Equity Research
Honeywell (HON) increases N95 face mask production at its Phoenix site to help contain the coronavirus pandemic.
United Technologies & Raytheon Get Final Approval for Merger
by Zacks Equity Research
United Technologies (UTX) and Raytheon receive all the regulatory approvals required for closing the merger of equals on Apr 3, 2020.
Nordson (NDSN) Announces Plan to Reorganize into 2 Businesses
by Zacks Equity Research
Nordson's (NDSN) business realignment will likely help it achieve its long-term priorities. It also intends on bringing its financial reporting on par with the new business structure.
TNC vs. IEX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TNC vs. IEX: Which Stock Is the Better Value Option?
Nordson (NDSN) Gains From Buyouts Despite Segmental Woes
by Zacks Equity Research
Nordson (NDSN) is likely to benefit from strength in its medical product end markets, growth initiatives and buyouts. Weak Advanced Technology Systems segment and high cost of sales remain concerning.
Applied Industrial Gains From Buyouts Despite Market Woes
by Zacks Equity Research
Applied Industrial (AIT) to gain from cost-saving measures, acquisitions and shareholder-friendly policies. Softness in industrial demand might impact near-term results.
Colfax (CFX) Displays Bright Prospects, Headwinds Remain
by Zacks Equity Research
Colfax (CFX) is likely to benefit from its focus on strengthening segmental businesses, productivity actions and acquisitions. However, rising cost of sales and high debt remain concerns.
The Zacks Analyst Blog Highlights: Tennant, eXp World, James River, Cornerstone Building Brands and Forterra
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Tennant, eXp World, James River, Cornerstone Building Brands and Forterra
iRobot (IRBT) Withdraws Annual View on Coronavirus Concerns
by Zacks Equity Research
Due to the pandemic, iRobot (IRBT) lowers sales view for first-quarter 2020 and withdraws annual projections. It expects to witness relief if Roomba products get excluded from Section 301 tariffs.
5 Must-Buy Small-Cap Growth Stocks for Long-Term Investors
by Nalak Das
Despite massive market mayhem, some small-cap stocks with strong growth potential for 2020, have witnessed upward EPS estimate revisions in the last 30 days.
Flowserve Down 59% YTD on Coronavirus & Other Global Woes
by Zacks Equity Research
Flowserve (FLS), with shares down 59% so far in 2020, faces risks from geopolitical and macroeconomic headwinds. The virus outbreak might hurt its China manufacturing operations and supplier networks.
Enerpac Tool (EPAC) Lags on Q2 Earnings, Discontinues View
by Zacks Equity Research
Enerpac Tool (EPAC) Q2 results reflect weak sales and operating performance. It discontinues the fiscal 2020 projections due to volatility in oil prices and the coronavirus outbreak.
Cintas (CTAS) Q3 Earnings & Revenues Beat Estimates, Up Y/Y
by Zacks Equity Research
Cintas' (CTAS) third-quarter fiscal 2020 earnings and revenues increase year over year due to strong performance in its segmental businesses.
Applied Industrial (AIT) Declines 52% YTD: What's Hurting it?
by Zacks Equity Research
Applied Industrial (AIT), with shares down 52% so far in 2020, faces headwinds from uncertain end-market conditions. Organic sales performance will likely be weak for both segments throughout the rest of fiscal 2020.
IDEX (IEX) Authorizes Share Repurchase Program Worth $500M
by Zacks Equity Research
IDEX's (IEX) approval of an additional share repurchase program worth $500 million is likely to instill confidence among investors.
Industrial Production Up M/M in February: 5 Stocks to Buy
by Payal Jalan
Industrial production rises m/m in February on strong manufacturing and utilities sectors. In spite of the rebound, the coronavirus threat remains. Amid this, five stocks might boost your portfolio.
Roper's (ROP) Rate Prediction Tools to be Used by Choptank
by Zacks Equity Research
Roper's (ROP) business unit, DAT Solutions' forecasting tools generate rate predictions on the basis of price momentum, prevailing market conditions as well as five years of historic data.
Roper (ROP) Displays Bright Prospects, Headwinds Persist
by Zacks Equity Research
Roper (ROP) is likely to benefit from strength across its network software and medical products businesses, and acquisitions. However, soft Process Technologies segment is a concern.